InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Erbitux patent dispute ends in $120 million deal

Eklavya Gupte, London


The worldwide Erbitux patent dispute reached the end of the road with a settlement between the parties last week

ImClone Systems and Sanofi-Aventis agreed to settle a row with Yeda Research Development Corporation over the ownership of the patent for the cancer drug on Friday.

The dispute has been raging worldwide since the patent, number 6,217,866, was granted by...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements